No. 1 is SCBGENOME(E) +62.13%
First Plus Healthcare FIF
Shows where this fund stands in its group. Not investment advice · Data as of 3 Nov 2026
FP HCARE-D invests through the master fund Manulife Global Fund – Healthcare Fund 98.25%
This fund and the master fund each charge their own fees. See the fees section of this page for the actual fees
Fact sheet checked on 30 Sep 2026 · Top 6 shown, the rest grouped as Other · per Manulife fact sheet
Over the past year it was in the top 25% of its group; over 5 years it returned +1.18% per year (Better than half the group)
No. 1 is SCBGENOME(E) +62.13%
Each bar is one fund in the AIMC Health Care group, sorted from highest to lowest return · Every share class is counted, and only funds with a full track record for the period are included · Calculated from NAV as of 3 Nov 2026
Past performance is not a guarantee of future results
| YTD | 1W | 2W | 1M | 3M | 6M | 1Y | 3Y | 5Y | 7Y | 10Y | MAX |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +18.55% | +3.78% | +5.44% | +12.18% | +11.62% | +22.28% | +26.67% | +13.89% | +6.06% | +32.07% | +38.04% |
Largest drawdown in the selected period −29.82% Previous peak 10 Jun 2024 (NAV 11.7224) → Trough 7 Aug 2025 (NAV 8.2262) · Back to the previous peak on 30 Oct 2026, after 1 year 2 months
Currently −0.22% from the peak NAV of 11.7579 (30 Oct 2026)
Over 5 years, FP HCARE-D returned 0.08 per unit of volatility, ranking 14 of 33 funds · The highest is TBIOTECH (0.26)
Paid 4 times in the past 12 months, totalling 0.6000 THB per unit, or 5.11% of NAV
FP HCARE-D pays cash dividends to unitholders from part of the fund's profit. Below is a summary of when you get paid, how much, and how regularly
You must buy and hold units before the book close to receive that round's dividend
The last 4 dividends Dec 25 0.2500 THB · Mar 26 0.1000 THB · Jun 26 0.1000 THB · Sep 26 0.1500 THB, and the next round is about 0.1500 THB on 15 Dec 2026Paid on schedule 4 times in a row, so the next round is estimated from this pattern · This is not an AMC announcement. The actual date and amount may differ, or no dividend may be paid
THB/unit, totalled by year of payment · * 2026 to 3 Nov 2026
Based on NAV 9.8160 → 11.7325 THB (3 Nov 2025 – 3 Nov 2026) and dividends over the same period
Unitholders' total value doesn't disappear. Part of it moves from the NAV into cash (the example assumes asset prices don't change that day) · See the D markers on the NAV chart
THB/unit by book-close date
(1) กองทุนเน้นลงทุนในหน่วยลงทุนของกองทุนรวมต่างประเทศเพียงกองทุนเดียวเฉลี่ยในรอบปีบัญชีไม่น้อยกว่าร้อยละ 80 ของมูลค่าทรัพย์สินสุทธิของกองทุน คือ Manulife Global Fund - Healthcare Fund (กองทุนหลัก) บริหารจัดการโดย Manulife Investment Management (US) LLC และเป็นกองทุนที่จดทะเบียนจัดตั้งและซื้อขายในประ… Its largest holdings are หน่วยลงทุนกองทนหลก 98.25% (fact sheet 30 Sep 2026)
Risk level 7 of 8 (High risk). Since 25 Mar 2016, its NAV has fallen as much as −29.82% from its peak.
Actual total expense ratio (TER) 2.19% a year, against a ceiling of 3.75%. Management fee 1.87%. Front-end fee 1.50%. (Fact sheet 30 Sep 2026)
Yes. The latest was 0.1500 THB per unit, book close 15 Sep 2026, paid 22 Sep 2026 · 4 payments so far, totalling 0.6000 THB per unit. Dividends are subject to 10% withholding tax and are not guaranteed
Minimum first purchase 1,000 THB, subsequent purchases not set. Buy orders accepted until 15:30, sell orders until 15:30, and redemption proceeds are paid T+5
Hedged at the manager's discretion. As of 30 Sep 2026, 14.65% of the value of its foreign investments was hedged
They are share classes of the same fund and invest in the same assets. They differ only in each class's terms, such as dividend policy, fees or who can buy · FP HCARE-D: pays dividends, TER 2.19% · FP HCARE-A: no dividends, TER 2.19%
Past performance is not a guarantee of future results · Investing involves risk. Investors should understand the product's features, return conditions and risks before making an investment decision · This fund invests abroad, so investors may lose or gain from exchange rate movements
Diabetes and weight-loss drugs
An American medicines and medical devices company, with products such as cancer drugs and surgical instruments
Hospitals, medicines and medical equipment
Hospitals, medicines and medical equipment
Hospitals, medicines and medical equipment
Hospitals, medicines and medical equipment
Hospitals, medicines and medical equipment
An American company selling scientific instruments, reagents and services for laboratories
Hospitals, medicines and medical equipment
Based on the master fund's share of this fund's value (98.25% as of 30 Sep 2026) × each stock's weight in the master fund · fact sheet from Manulife · Illustrations are for explanation only, not individual stock recommendations
No. 1 is SCBGENOME(E) +21.97% per year
No. 1 is FP HCARE-A +6.61% per year
| +19.47% |
Total return over each period, matching the NAV chart periods · Not annualised
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Full year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −0.2 | +3.0 | −3.6 | −2.1 | +2.4 | +6.3 | +1.1 | +1.5 | −0.6 | +10.3 | −0.2 | · | +18.5* |
| 2025 | +5.3 | +2.3 | −4.8 | −3.1 | −6.9 | +1.9 | +1.7 | +1.2 | +1.4 | +4.9 | +9.5 | −2.6 | +10.3 |
| 2024 | +5.9 | +3.5 | +0.1 | −1.6 | +0.7 | −1.7 | −0.9 | +0.2 | −12.1 | −0.2 | +1.0 | −9.1 | −14.7 |
| 2023 | −6.8 | +3.0 | −1.1 | +3.2 | −2.3 | +3.4 | −1.3 | +2.4 | −2.8 | −3.6 | +2.4 | +1.8 | −2.2 |
| 2022 | −7.2 | −3.5 | +7.0 | −0.3 | −1.2 | −0.8 | +6.7 | −5.1 | −0.3 | +6.2 | −4.0 | −2.0 | −5.4 |
0 of 4 book-close dates match the SEC dividend history · The rest are inferred from the dates NAV fell by the dividend amount